EMPLOYMENT AGREEMENTEmployment Agreement • January 31st, 2022 • Inotiv, Inc. • Services-commercial physical & biological research • Indiana
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of January 27, 2022, by and between INOTIV, INC., an Indiana corporation (the “Company”), and ROBERT LEASURE, JR. (the “Executive”).
RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • January 31st, 2022 • Inotiv, Inc. • Services-commercial physical & biological research • Indiana
This Restricted Stock Unit Award Agreement is entered into by and between Inotiv, Inc., an Indiana corporation (“Company”), and [Participant], an officer of the Company (“Grantee”), effective as of _______ __, 20__ (“Effective Date”).
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • January 31st, 2022 • Inotiv, Inc. • Services-commercial physical & biological research • New York
This CREDIT AGREEMENT (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), dated as of November 5, 2021, among INOTIV, INC., an Indiana corporation (the “Borrower”), the Subsidiary Guarantors (such term and each other capitalized term used but not defined herein having the meaning given to it in Article I), the Lenders from time to time party hereto and Jefferies Finance LLC, as administrative agent for the Lenders (in such capacity, together with its successors and permitted assigns, the “Administrative Agent”) and as collateral agent for the Secured Parties (in such capacity, together with its successors and permitted assigns, the “Collateral Agent”); with Jefferies Finance LLC, as sole lead arranger (in such capacity, the “Arranger”) and sole bookrunner (in such capacity, the “Bookrunner”).
STOCK PURCHASE AGREEMENT By and among ENVIGO GLOBAL SERVICES INC. INOTIV, INC. and ORIENT BIO, INC. Dated January 27, 2022Stock Purchase Agreement • January 31st, 2022 • Inotiv, Inc. • Services-commercial physical & biological research • Texas
THIS STOCK PURCHASE AGREEMENT (this "Agreement") is being entered into effective as of January 27, 2022, by and among Envigo Global Services Inc., a Pennsylvania corporation ("Buyer"), Inotiv, Inc., an Indiana corporation ("Parent"), and Orient Bio, Inc., a corporation formed in the Republic of Korea ("Seller").
